Gender Disparities in CAD: Women and Ischemic Heart Disease
- PMID: 30178384
- DOI: 10.1007/s11883-018-0753-7
Gender Disparities in CAD: Women and Ischemic Heart Disease
Abstract
Purpose of review: The goal of this article is to review the disparities that exist for women who present for treatment of ischemic heart disease.
Recent findings: It is well known that women are more likely to present with ischemic heart disease at an advanced age with more comorbidities when compared to male counterparts. Despite correction of risk factors, women experience worse outcomes, even in the absence of obstructive coronary artery disease. A review of the literature highlights the importance of a thoughtful approach to medical therapy and revascularization. While most recommendations applied to women are derived mostly from male data, further study of sex-specific differences may lead to approaches which can ultimately reduce disparities for the treatment of ischemic heart disease in women.
Keywords: Acute coronary syndrome; Gender disparities; Ischemic heart disease; Women.
Similar articles
-
Treatment of Coronary Artery Disease in Women.Methodist Debakey Cardiovasc J. 2017 Oct-Dec;13(4):201-208. doi: 10.14797/mdcj-13-4-201. Methodist Debakey Cardiovasc J. 2017. PMID: 29744012 Free PMC article. Review.
-
Gender Disparities Across the Spectrum of Advanced Cardiac Therapies: Real or Imagined?Curr Cardiol Rep. 2016 Nov;18(11):108. doi: 10.1007/s11886-016-0783-0. Curr Cardiol Rep. 2016. PMID: 27628294 Review.
-
Sex differences in nonobstructive coronary artery disease: Recent insights and substantial knowledge gaps.Trends Cardiovasc Med. 2017 Apr;27(3):173-179. doi: 10.1016/j.tcm.2016.08.002. Epub 2016 Aug 11. Trends Cardiovasc Med. 2017. PMID: 27617797 Review.
-
Sex and gender differences in coronary artery disease.Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):126-30. doi: 10.1053/j.semtcvs.2011.07.006. Semin Thorac Cardiovasc Surg. 2011. PMID: 22041042 Review.
-
Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps.Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004437. doi: 10.1161/CIRCOUTCOMES.117.004437. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29449443 Review.
Cited by
-
Age at menarche and ischemic heart disease: An update mendelian randomization study.Front Genet. 2022 Nov 3;13:942861. doi: 10.3389/fgene.2022.942861. eCollection 2022. Front Genet. 2022. PMID: 36406117 Free PMC article.
-
Risk of Ischemic Heart Disease Associated with Primary Dysmenorrhea: A Population-Based Retrospective Cohort Study.J Pers Med. 2022 Sep 29;12(10):1610. doi: 10.3390/jpm12101610. J Pers Med. 2022. PMID: 36294749 Free PMC article.
-
Global burden of cardiovascular disease attributable to metabolic risk factors, 1990-2019: an analysis of observational data from a 2019 Global Burden of Disease study.BMJ Open. 2023 May 12;13(5):e069397. doi: 10.1136/bmjopen-2022-069397. BMJ Open. 2023. PMID: 37173115 Free PMC article.
-
Changing patterns of cardiovascular diseases and subtypes induced by kidney dysfunction among 25-64 years in China from 1992 to 2021.BMC Public Health. 2025 Jan 3;25(1):26. doi: 10.1186/s12889-024-21183-4. BMC Public Health. 2025. PMID: 39754057 Free PMC article.
-
Role of the renin-angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products.Front Physiol. 2023 Feb 23;14:1034170. doi: 10.3389/fphys.2023.1034170. eCollection 2023. Front Physiol. 2023. PMID: 36909245 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous